chr10-7963996-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031923.4(TAF3):āc.486T>Gā(p.Asp162Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000155 in 1,613,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_031923.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAF3 | NM_031923.4 | c.486T>G | p.Asp162Glu | missense_variant | 3/7 | ENST00000344293.6 | |
TAF3 | XM_011519741.2 | c.483T>G | p.Asp161Glu | missense_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAF3 | ENST00000344293.6 | c.486T>G | p.Asp162Glu | missense_variant | 3/7 | 1 | NM_031923.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151966Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249098Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135140
GnomAD4 exome AF: 0.000165 AC: 241AN: 1461856Hom.: 0 Cov.: 30 AF XY: 0.000165 AC XY: 120AN XY: 727234
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151966Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74208
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2022 | The c.486T>G (p.D162E) alteration is located in exon 3 (coding exon 3) of the TAF3 gene. This alteration results from a T to G substitution at nucleotide position 486, causing the aspartic acid (D) at amino acid position 162 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at